Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a target for drug development in the treatement of Human African trypanosomiasis (HAT), an infectious disease caused by two distinct subspecies of the protozoan parasite Trypanosoma brucei subsp. gambiense and Trypanosoma brucei subsp. rhodesiense | Trypanosoma brucei |
Cloned (Comment) | Organism |
---|---|
recombinant expression of bifunctional Trypanosoma brucei DHFR-TS in form of a fusion protein incorporating Escherichia coli elongation factor Ts (Tsf), in Escherichia coli strain BL21 Star (DE3). The Tsf open reading frame is amplified by PCR from the genomic DNA of Eschrichia coli strain K12, cloning procedure overview. Expression constructs carrying a thymidylate synthase (TS) domain from Trypanosoma brucei, Leishmania major and Homo sapiens are expressed in a TS-deficient Escherichia coli strain (thyA-), while TbDHFR without thymidylate synthase is expressed in the parental thyA+ strain | Trypanosoma brucei |
Protein Variants | Comment | Organism |
---|---|---|
additional information | DHFR activity in lysates of Escherichia coli expressing Tsf-TbDHFR-TS is about 6fold more active than those expressing His6-TbDHFR-TS. In addition, thymidylate synthase activity, which has proved elusive with the His6-protein, is detectable. Stabilization of the TS activity with dUMP, without affect on DHFR stability. No stabilisation observed with CH2THF and other pyrimidine nucleotides, including the uracil-containing ribonucleotides and deoxyribonucleotides, and the thymidine-containing deoxyribonucleotides, overview | Trypanosoma brucei |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
5-fluorodeoxyuridine monophosphate | - |
Trypanosoma brucei | |
5-fluorouracil | - |
Trypanosoma brucei | |
methotrexate | - |
Trypanosoma brucei | |
additional information | analysis of enzyme susceptibility to a range of classical inhibitors normally used in the treatment of cancer, bacterial or protozoal infections, in vivo effects in presence of absence of thymidine and/or folate, overview. Modulating certain medium components can affect drug sensitivity, presumably by either competition for uptake and competition for the active site of DHFR-TS. In the case of one human thymidylate synthase inhibitor raltitrexed, the inhibitor is more potent against the intact parasite. Addition of extra glutamic acid residues not only improves retention in the cell, but also increases potency against thymidylate synthase, as it does in human cells. No inhibition by FdUMP | Trypanosoma brucei | |
nolatrexed | - |
Trypanosoma brucei | |
pemetrexed | - |
Trypanosoma brucei | |
pyrimethamine | - |
Trypanosoma brucei | |
raltitrexed | - |
Trypanosoma brucei | |
trimethoprim | - |
Trypanosoma brucei | |
trimetrexate | - |
Trypanosoma brucei |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | Michaelis-Menten kinetics | Trypanosoma brucei |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
KCl | the optimal ionic strength for both enzymes requires 100 mM KCl, with DHFR displaying 2.5fold activation and TS 4.5fold activation | Trypanosoma brucei | |
Mg2+ | TS is activated 4.5fold at 10 mM MgCl2, but inhibited at higher concentrations of MgCl2. The activating effect is not additive with activation by KCl | Trypanosoma brucei |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
5,10-methylenetetrahydrofolate + dUMP | Trypanosoma brucei | - |
dihydrofolate + dTMP | - |
? | |
additional information | Trypanosoma brucei | the bifunctional folate and pyrimidine-metabolising enzyme dihydrofolate reductase-thymidylate synthase dihydrofolate reductase-thymidylate synthase is expressed from a single gene as a homodimer comprising of an N-terminal DHFR domain fused via a linker peptide to a thymidylate synthase domain at the C-terminus | ? | - |
? | |
additional information | Trypanosoma brucei 427 | the bifunctional folate and pyrimidine-metabolising enzyme dihydrofolate reductase-thymidylate synthase dihydrofolate reductase-thymidylate synthase is expressed from a single gene as a homodimer comprising of an N-terminal DHFR domain fused via a linker peptide to a thymidylate synthase domain at the C-terminus | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Trypanosoma brucei | Q27783 | - |
- |
Trypanosoma brucei 427 | Q27783 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant Trypanosoma brucei Tsf-DHFR-TS from Escherichia coli strain BL21 Star (DE3) by methotrexate affinity chromatography and gel filtration | Trypanosoma brucei |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.0088 | - |
purified recombinant bifunctional enzyme DHFR-TS with Tsf tag, pH 7.4, 25°C from a TS-deficient Escherichia coli strain (thyA-) | Trypanosoma brucei |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5,10-methylenetetrahydrofolate + dUMP | - |
Trypanosoma brucei | dihydrofolate + dTMP | - |
? | |
additional information | the bifunctional folate and pyrimidine-metabolising enzyme dihydrofolate reductase-thymidylate synthase dihydrofolate reductase-thymidylate synthase is expressed from a single gene as a homodimer comprising of an N-terminal DHFR domain fused via a linker peptide to a thymidylate synthase domain at the C-terminus | Trypanosoma brucei | ? | - |
? | |
additional information | no activity with folic acid and the structurally related pterins (biopterin, dihydrobiopterin, sepiapterin and neopterin) as substrates by enzyme DHFR-TS | Trypanosoma brucei | ? | - |
? | |
additional information | the bifunctional folate and pyrimidine-metabolising enzyme dihydrofolate reductase-thymidylate synthase dihydrofolate reductase-thymidylate synthase is expressed from a single gene as a homodimer comprising of an N-terminal DHFR domain fused via a linker peptide to a thymidylate synthase domain at the C-terminus | Trypanosoma brucei 427 | ? | - |
? | |
additional information | no activity with folic acid and the structurally related pterins (biopterin, dihydrobiopterin, sepiapterin and neopterin) as substrates by enzyme DHFR-TS | Trypanosoma brucei 427 | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | the bifunctional folate and pyrimidine-metabolising enzyme dihydrofolate reductase-thymidylate synthase dihydrofolate reductase-thymidylate synthase is expressed from a single gene as a homodimer comprising of an N-terminal DHFR domain fused via a linker peptide to a TS domain at the C-terminus | Trypanosoma brucei |
Synonyms | Comment | Organism |
---|---|---|
DHFR-TS | - |
Trypanosoma brucei |
dihydrofolate reductase-thymidylate synthase | - |
Trypanosoma brucei |
More | cf. EC 1.5.1.3 | Trypanosoma brucei |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Trypanosoma brucei |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7 | - |
TS activity | Trypanosoma brucei |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADP+ | - |
Trypanosoma brucei | |
NADPH | - |
Trypanosoma brucei |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000000095 | - |
methotrexate | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.000000597 | - |
trimetrexate | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.00000635 | - |
pyrimethamine | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.0000176 | - |
trimethoprim | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.0000931 | - |
raltitrexed | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.00029 | - |
pemetrexed | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei | |
0.000348 | - |
nolatrexed | pH 7.4, 25°C, recombinant enzyme | Trypanosoma brucei |
Organism | Comment | Expression |
---|---|---|
Trypanosoma brucei | DHFR activity in lysates of Escherichia coli expressing Tsf-TbDHFR-TS is about 6fold more active than those expressing His6-TbDHFR-TS. In addition, thymidylate synthase activity, which has proved elusive with the His6-protein, is detectable. Stabilization of the TS activity with dUMP, without affect on DHFR stability. No stabilisation observed with CH2THF and other pyrimidine nucleotides, including the uracil-containing ribonucleotides and deoxyribonucleotides, and the thymidine-containing deoxyribonucleotides, overview | additional information |
General Information | Comment | Organism |
---|---|---|
physiological function | DHFR-TS is essential for cell survival of Trypanosoma brucei | Trypanosoma brucei |